Trupanion (NASDAQ:TRUP) Releases Earnings Results, Beats Estimates By $0.05 EPS

Trupanion (NASDAQ:TRUP) released its earnings results on Thursday. The financial services provider reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.05, FiscalAI reports. The company had revenue of $405.59 million during the quarter, compared to analyst estimates of $402.53 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. During the same period in the prior year, the company posted $0.13 earnings per share.

Here are the key takeaways from Trupanion’s conference call:

• Trupanion reported record third-quarter adjusted operating income of $47 million, up 15% year over year, on revenue of $405.6 million, up 11%. Free cash flow also reached a record $28.5 million, and the company reported its sixth consecutive quarter of positive net income.
• Growth and customer metrics improved: net new pets exceeded 20,500, up more than 28% year over year, while average monthly retention rose for the seventh consecutive quarter to 98.38%. Management attributed stronger conversion and lower acquisition cost per pet in part to expanded plan options and digital enrollment improvements.
• The company raised the midpoint of its full-year adjusted operating income outlook to $180.5 million, implying about 19% year-over-year growth, and expects fourth-quarter adjusted operating income of $48 million to $51 million. Full-year subscription revenue is now expected to grow about 14% at the midpoint.
• Management expects veterinary cost inflation to remain in the double digits into 2027, requiring continued pricing adjustments. It said average member increases may ease as pricing catches up with costs, but affordability remains an important consideration.
• Trupanion repurchased about $25 million of shares in the quarter and repaid $15 million of borrowings after quarter-end, while continuing to fund growth initiatives. Its Landspath pet-food trials are underway, but management expects limited revenue from the initiative over the next 18 months.

Trupanion Stock Performance

Shares of TRUP stock traded up $1.04 during trading hours on Friday, hitting $35.77. 79,416 shares of the company were exchanged, compared to its average volume of 435,790. The firm has a fifty day simple moving average of $27.00 and a 200 day simple moving average of $26.66. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion has a 52-week low of $21.16 and a 52-week high of $46.98. The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of 67.47, a P/E/G ratio of 2.01 and a beta of 1.27.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total transaction of $183,391.11. Following the completion of the transaction, the chief financial officer directly owned 4,230 shares of the company’s stock, valued at approximately $126,942.30. This represents a 59.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO John R. Gallagher sold 3,604 shares of the firm’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the sale, the chief operating officer directly owned 33,742 shares of the company’s stock, valued at $1,002,137.40. This represents a 9.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 14,046 shares of company stock valued at $407,743. 5.58% of the stock is owned by company insiders.

Key Trupanion News

Here are the key news stories impacting Trupanion this week:

• Positive Sentiment: Trupanion reported Q3 revenue of $405.6 million, ahead of the roughly $402.5 million analyst estimate. Reported EPS was $0.21 versus consensus of $0.16, up from $0.13 a year earlier. Zacks earnings report
• Positive Sentiment: The earnings-call recap cited record adjusted operating income, while another report emphasized record cash flow—potential signs of stronger operating performance and cash generation. Earnings call highlights
• Neutral Sentiment: Coverage characterized EPS differently: while headline reported EPS beat estimates, 24/7 Wall St. described a sharp EPS miss alongside record cash flow. Investors may want to distinguish between the earnings measures used when assessing the results. 24/7 Wall St. earnings analysis
• Negative Sentiment: Industry commentary cautioned that rising medical costs and inflation can pressure pricing and underwriting margins, a risk for insurers including Trupanion. Insurance industry outlook

Analyst Ratings Changes

A number of analysts recently commented on TRUP shares. Weiss Ratings upgraded Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Atlantic Securities set a $42.00 price objective on Trupanion in a research note on Wednesday, July 15th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Cantor Fitzgerald decreased their target price on Trupanion from $34.00 to $30.00 and set a “neutral” rating for the company in a research report on Wednesday, October 7th. Finally, Piper Sandler lowered Trupanion from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $45.00 to $32.00 in a research report on Wednesday, August 26th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $38.40.

Trupanion Company Profile

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.